Related Experiment Video

Updated: May 13, 2026

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

Redefinition of gestational diabetes mellitus: implications for laboratory practice in Croatia

Marijana Vucić Lovrencić, Lorena Honović, Sasa Kralik

    Biochemia Medica
    |March 6, 2013
    PubMed

    Insights

    Gestational diabetes diagnosis is challenging globally. Croatia is implementing new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria for improved prenatal care and laboratory standardization.

    Area of Science:

    • Obstetrics and Gynecology
    • Endocrinology
    • Clinical Biochemistry

    Background:

    • Rising global prevalence of gestational diabetes mellitus (GDM) presents significant prenatal care challenges.
    • The International Association of Diabetes and Pregnancy Study Groups (IADPSG) has established harmonized, evidence-based criteria for diagnosing hyperglycemia in pregnancy.
    • These IADPSG recommendations necessitate adjustments in clinical and laboratory practices worldwide.

    Discussion:

    • Croatia, through its Perinatology Society, has adopted the IADPSG criteria, initiating a new strategy for GDM detection and diagnosis.
    • A dedicated Working Group was formed to develop standardized laboratory procedures for GDM diagnosis, ensuring consistency across healthcare facilities.
    • Successful implementation requires careful planning and adaptation to national healthcare specificities.

    Key Insights:

    • The IADPSG criteria offer a unified approach to diagnosing GDM, crucial for consistent patient management.
    • Standardized laboratory protocols are essential for the accurate and reliable application of the new diagnostic criteria.
    • Collaboration between clinical and laboratory professionals is vital for effective GDM screening and diagnosis.

    Outlook:

    • The adoption of IADPSG criteria is expected to enhance the quality of prenatal care and GDM management in Croatia.
    • Further research may focus on long-term outcomes and cost-effectiveness of the implemented diagnostic strategy.
    • International collaboration can facilitate the sharing of best practices for GDM diagnosis and care.

    More Related Videos

    Improving IV Insulin Administration in a Community Hospital12:08

    Improving IV Insulin Administration in a Community Hospital

    Published on: June 11, 2012

    Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test06:59

    Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test

    Published on: November 13, 2016

    Related Concept Videos

    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

    Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

    Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
    Diabetes Mellitus: Introduction01:26

    Diabetes Mellitus: Introduction

    Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
    Type I Diabetes III: Clinical Manifestations01:19

    Type I Diabetes III: Clinical Manifestations

    Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
    Hyperglycemia01:29

    Hyperglycemia

    Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...